- 3-6 months initial treatment
- 8-16 weeks for clinical improvement
- 78%
China versus the U.S.
- China clinical rate
- $800 – $4,000
- $2,400
- United States
- $3,500 – $18,000
- $10,750
- You save
- ~78%
- $8,350 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Integrated psoriatic arthritis management addressing both joint inflammation and skin disease with biologics and targeted therapies. Chinese dermatology-rheumatology teams provide coordinated care using IL-17 and IL-23 inhibitors alongside traditional Chinese medicine for skin manifestations. Treatment protocols focus on achieving minimal disease activity across all domains.
Step by step.
Multidomain Assessment
Joint examination, skin severity scoring (PASI), nail assessment, enthesitis evaluation, and imaging studies
Targeted Biologic Selection
Initiate IL-17 inhibitor (secukinumab), IL-23 inhibitor (guselkumab), or TNF inhibitor based on dominant domains
Skin-Joint Optimization
Adjust therapy to achieve dual-domain control, add topical treatments for skin, and physical therapy for joints
TCM Dermatology Support
Chinese herbal medicine for skin clearance, medicated baths, and anti-inflammatory dietary guidance
- Coordinated rheumatology-dermatology care under one roof
- Access to affordable biologic agents targeting both skin and joints
- TCM herbal approaches for additional skin improvement
- Lower overall treatment costs for long-term biologic therapy
- Increased infection risk from immunosuppression
- Potential paradoxical psoriasis worsening with some biologics
- Candida infections more common with IL-17 inhibitors
- Treatment adjustments needed for incomplete response
Ask the AI for hospitals that handle psoriatic arthritis treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.